一种基于生理学的药理动力学建模方法,用于在ECMO上给儿童注射阿米奥达龙
Venkata K Yellepeddi1,2, John Porter Hunt1, Danielle J Green1,3
1Division of Clinical Pharmacology, Department of Pediatrics, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, USA.
CPT: pharmacometrics & systems pharmacology
|July 21, 2024
概括
这项研究开发了一种药理动力学模型,以确定外体膜氧化 (ECMO) 的儿科患者的阿米奥达龙剂量. 模拟表明特定的静脉注射剂量新生儿,婴儿,儿童和青少年在ECMO.
科学领域:
- 药理学 药理学是指药理学的学科.
- 儿科重症监护 儿科重症监护
- 计算机建模 计算建模
背景情况:
- 身体外膜氧化 (ECMO) 对儿科心脏骤停至关重要.
- 艾米奥达龙推用于心室节律失常,但缺乏儿科ECMO剂量指南.
- 药物对ECMO成分的吸附改变了药理动力学,需要特定的剂量策略.
研究的目的:
- 在儿科ECMO患者中开发阿米奥达龙的生理学基础的药理动力学 (PBPK) 模型.
- 建立基于证据的阿米奥达龙剂量建议,用于ECMO治疗的儿科患者.
- 证明PBPK建模对优化儿科ECMO药物治疗的实用性.
主要方法:
- 开发了一种阿米奥达龙的PBPK模型,从成年人扩展到具有特定年龄CYP450成熟的儿童.
- 包含一个ECMO隔间,参数化与体外阿米奥达龙吸附数据.
- 针对儿科ECMO患者观察到的阿米奥达龙度的验证模型预测.
主要成果:
- 该PBPK模型准确地预测了儿科ECMO患者的阿米奥达龙度 (平均折叠误差为0.5-2).
- 模拟支持特定的静脉注射. 玻尿酸剂量:新生儿22 mg/kg,婴儿13 mg/kg,儿童8 mg/kg,青少年6 mg/kg.
- 该模型成功地解释了阿米奥达龙对ECMO电路的吸附.
结论:
- 基于生理学的药理动力学建模为确定儿科ECMO中阿米奥达龙剂量提供了可靠的方法.
- 在需要ECMO的儿科患者中,推的阿米奥达龙剂量因年龄组而异.
- 这种PBPK方法可以指导用于儿科ECMO的其他药物的剂量.
相关概念视频
01:26Pharmacokinetic Models: Comparison and Selection Criterion
66
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
66
01:20Pharmacokinetic Models: Overview
643
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
643
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
182
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
182
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
67
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
67
00:57Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
77
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
77
01:09One-Compartment Model: IV Infusion
186
Intravenous (IV) infusion is often utilized when continuous and controlled drug delivery is necessary, such as during surgery or in the treatment of chronic diseases. This method offers numerous advantages, including immediate drug action, precise control over dosage, and bypassing the first-pass metabolism.
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
186